Prefilled Syringes Market worth $14.53 billion by 2031
The report "Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), & Region – Global Forecast to 2031", is projected to grow from USD 8.65 billion in 2026 and to reach USD 14.53 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 10.9% during the forecast period.
Browse 250 market data Tables and 60 Figures spread through 300 Pages and in-depth TOC on "Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), & Region – Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/prefilled-syringes-market-16618331.html
The growth of the prefilled syringes market is primarily driven by the rising prevalence of chronic diseases requiring long-term therapies, coupled with the growing elderly population globally, and the increasing adoption of biological drugs, which often require precise dosing and administration. However, stringent regulations for approval processes and safety issues associated with prefilled syringes can affect market growth, requiring continuous innovation and rigorous testing to overcome these barriers.
The conventional prefilled syringes segment accounted for the largest share, by type, of the prefilled syringes market in 2025.
The conventional prefilled syringes segment holds the largest share of the prefilled syringes market due to its widespread adoption across various therapeutic areas. These syringes are pre-filled with a specific dosage of medication, ensuring convenience and precise dosing for healthcare providers and patients. They are favored for their ease of use, reduced risk of contamination, and compatibility with a wide range of drugs. This segment's dominance is driven by its versatility and the established manufacturing processes that support large-scale production to meet global healthcare demands effectively. Conventional prefilled syringes contribute a significant portion to the overall share of the prefilled syringes segment because they are widely utilized in various therapeutic applications. These syringes come prefilled with a particular dosage of medication, ensuring ease of use and accurate/precise doses for healthcare providers as well as patients. They are user-friendly, have a reduced chance of contributing to contamination, and are compatible with a variety of drugs. The versatility of this segment complements established manufacturing methods in high-scale production to ensure adequate supply to global healthcare needs.
The glass prefilled syringes segment accounted for the largest share, by material, of the prefilled syringes market in 2025.
The glass prefilled syringes segment holds the largest share of the prefilled syringes market primarily due to its superior material properties and suitability for sensitive formulations of drugs. In general, glass syringes have some inherent advantages because they are inert; therefore, the risk of drug interaction or leaching is minimal. They are therefore ideal for biologics, vaccines, and other complex formulations. In addition, glass syringes are clear and allow the drug to be seen, allowing for accurate dosage administration. The glass syringes are less durable than plastic syringes, but improvements in glass technology have made glass syringes safer and more robust, thus reinforcing their dominance in the market.
The single-chamber prefilled syringes segment accounted for the largest share, by design, of the prefilled syringes market in 2025.
The single-chamber prefilled syringes segment commands the largest share of the prefilled syringes market due to their simplicity and cheapness for drug delivery. These syringes come prefilled with a single compartment containing a specific medication, thus rendering them simple to fabricate and operate. For ease of handling and diminished risk of medication errors, these types of syringes find extensive applications in a range of therapeutic areas—from vaccine delivery to insulin administration.
The cancer segment accounted for the largest share, by application, of the prefilled syringes market in 2025.
The cancer segment holds the largest share of the prefilled syringes market owing to the increasing prevalence and the rising demand for precise and targeted drug delivery systems. Among the significant advantages of prefilled syringes in oncology treatments are accurate dosing, reduced risk of contamination, and superior patient compliance. They can be used for the delivery of chemotherapeutics, monoclonal antibodies, and supportive care drugs, thus enabling tailored approaches to therapy and better patient outcomes. This segment's performance alludes to the indispensable contribution of prefilled syringes to advanced cancer treatments and continued innovations aimed at addressing specific oncological conditions.
In 2025, North America accounted for the largest share of the prefilled syringes market.
The prefilled syringes market is segmented into six major regions: North America, Europe, Asia Pacific (APAC), Latin America, the Middle East & Africa, and the GCC Countries.
North America holds the largest share of the prefilled syringes market due to an advanced healthcare infrastructure, an impressively high adoption of advanced medical technologies, and extensive investments in drug development and research. The North American position is beneficially supported by strict regulatory standards that endorse the use of prefilled syringes for effective and safe drug delivery. In addition, with an increase in chronic diseases, the demand for prefilled syringes in North America is rising. Further, the presence of numerous pharmaceutical companies and biotechnology firms enhances the growth of the market.
Key Market Players
The key players in the global prefilled syringes market are BD (US), Gerresheimer AG (Germany), SCHOTT (Germany), West Pharmaceutical Services, Inc. (US), AptarGroup Inc. (US), Nipro (Japan), Baxter (US), Owen Mumford Ltd. (UK), Weigao Medical International Co., Ltd. (China), Credence MedSystems, Inc. (US), Novartis AG (Switzerland), Stevanato Group (Italy), Polymedicure (India), MedXL (Canada), Sharps Technology, Inc. (US), Fresenius Kabi (US), DBM S.R.L. (Italy), Taisei Kako Co., Ltd. (Japan), Shandong Province Medicinal Glass Co., Ltd. (China), SHIN YAN SHENO PRECISION INDUSTRIAL CO., LTD. (Japan), J.O. PHARMA CO., LTD. (Japan), BMIKOREA (Korea), B. Braun SE ( Germany), and Al Shifa Medical Products Co. (Saudi Arabia).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Prefilled Syringes Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
